Cymbalta and Pancreatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cymbalta and Pancreatin. Common interactions include dry eye among females and gingival abscess among males.

The phase IV clinical study analyzes what interactions people who take Cymbalta and Pancreatin have. It is created by eHealthMe based on reports of 23 people who take Cymbalta and Pancreatin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

23 people who take Cymbalta and Pancreatin together, and have interactions are studied.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 145,347 Cymbalta users for its effectiveness, alternative drugs and more.

What is Pancreatin?

Pancreatin has active ingredients of pancreatin. eHealthMe is studying from 1,671 Pancreatin users for its effectiveness, alternative drugs and more.

Number of Cymbalta and Pancreatin reports submitted per year:

Common Cymbalta and Pancreatin drug interactions by gender *:

female:

Dry eye
Neuropathy peripheral
Raynaud's phenomenon
Restless legs syndrome
Diarrhoea
Pain
Rheumatoid arthritis
Asthenia
Constipation
Drug administration error

male:

Gingival abscess
Gingivitis
Pain
Respiratory failure
Ventricular tachycardia
Arthralgia
Back disorder
Death
Dry mouth
Dry skin

Common Cymbalta and Pancreatin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Gingival abscess
Gingivitis
Malaise
Oral herpes
Pain
Pyrexia
Candida sepsis
Infection
Respiratory failure
Ventricular tachycardia

30-39:

Pulmonary embolism

40-49:

Oesophageal stenosis
Oesophageal ulcer
Oesophagitis

50-59:

Connective tissue disorder
Dyskinesia
Insomnia
Restlessness
Swelling
Tremor
Weight decreased
Dry eye
Neuropathy peripheral
Raynaud's phenomenon

60+:

Hypoaesthesia
Liver disorder
Dementia
Drug ineffective
Epilepsy

Common conditions people have *:

Insomnia (sleeplessness): 7 people, 30.43%
Constipation: 7 people, 30.43%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 26.09%
Familial Mediterranean Fever (genetic disease recurring attacks of abdominal pain, fever, pleurisy, arthritis, and rash): 4 people, 17.39%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 17.39%
Drowsiness: 4 people, 17.39%
Asthma: 4 people, 17.39%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 13.04%
High Blood Pressure: 3 people, 13.04%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Cymbalta and Pancreatin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.